Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALDX

Aldeyra Therapeutics Inc

May 22 • 04:00PM ET

1.55

-0.04 -2.52 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: EYPT OCGN TRVI VNDA SGMO

| Held by: VTI IWM VXF IWO VTWO VHT IWC DFMC PRFZ ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.46	Insider Own	3.18%	Shs Outstand	60.32M	Perf Week	-7.74%
Market Cap	93.50M	Forward P/E	-	EPS next Y	-0.23	Insider Trans	4.07%	Shs Float	58.40M	Perf Month	-3.13%
Enterprise Value	44.01M	PEG	-	EPS next Q	-0.07	Inst Own	62.18%	Short Float	12.61%	Perf Quarter	-68.94%
Income	-27.37M	P/S	-	EPS this Y	25.45%	Inst Trans	-6.92%	Short Ratio	2.40	Perf Half Y	-68.11%
Sales	0.00M	P/B	2.22	EPS next Y	44.11%	ROA	-34.28%	Short Interest	7.36M	Perf YTD	-70.08%
Book/sh	0.70	P/C	1.44	EPS next 5Y	-	ROE	-51.76%	52W High	6.18 -74.90%	Perf Year	-31.11%
Cash/sh	1.08	P/FCF	-	EPS past 3/5Y	19.04% 12.61%	ROIC	-64.92%	52W Low	1.07 44.86%	Perf 3Y	-84.12%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.22% 5.75%	Perf 5Y	-86.79%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	53.00%	Oper. Margin	-	ATR (14)	0.12	Perf 10Y	-70.48%
Dividend Ex-Date	-	Quick Ratio	2.69	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	36.59	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.69	EPS Q/Q	65.50%	SMA20	-5.02%	Beta	1.15	Target Price	7.00
Payout	-	Debt/Eq	0.37	Sales Q/Q	-	SMA50	-12.82%	Rel Volume	0.15	Prev Close	1.59
Employees	8	LT Debt/Eq	0.00	Earnings	Mar 12	SMA200	-64.08%	Avg Volume	3.07M	Price	1.55
IPO	May 02, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.43% -	Trades		Volume	466,737	Change	-2.52%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)